MedVellum
MedVellum
Back to Library

Intracranial Haemorrhage

On This Page

Overview

Intracranial Haemorrhage

Quick Reference

Critical Alerts

  • Time-critical diagnosis: CT head without contrast immediately
  • Blood pressure management is crucial: Aggressive lowering for ICH (target SBP <140)
  • Reverse anticoagulation urgently: Every minute counts for hematoma expansion
  • SAH may have negative CT: LP required if high suspicion and CT normal
  • Herniation signs require immediate action: Osmotherapy and neurosurgery
  • Airway protection: GCS ≤8 requires intubation

Key Diagnostics

TestFindingSignificance
CT Head Non-ContrastHyperdense lesionGold standard initial imaging
CT AngiographySpot sign, aneurysm, AVMIdentifies source, predicts expansion
LP (if CT-negative SAH suspected)Xanthochromia, elevated RBCsDiagnoses SAH
Coagulation studiesPT/INR elevatedGuides reversal therapy
Platelet countThrombocytopeniaMay need transfusion

Emergency Treatments

ConditionTreatmentDetails
BP control (ICH)Nicardipine or LabetalolTarget SBP <140 mmHg
Warfarin reversal4-factor PCC + Vitamin K25-50 units/kg + 10mg IV
DOAC reversalIdarucizumab (dabigatran) or Andexanet/PCCPer protocol
Elevated ICPMannitol or Hypertonic saline1g/kg or 23.4% 30mL
Seizure prophylaxisLevetiracetam20mg/kg IV (controversial)

Definition

Overview

Intracranial haemorrhage (ICH) refers to bleeding within the cranial vault, including the brain parenchyma, subarachnoid space, subdural space, or epidural space. It is a medical emergency with high mortality and morbidity requiring rapid diagnosis, blood pressure control, reversal of anticoagulation, and neurosurgical evaluation.

Classification

By Location:

TypeLocationCommon Causes
Intracerebral (ICH)Within brain parenchymaHypertension, CAA, AVM
Subarachnoid (SAH)Subarachnoid spaceAneurysm rupture, trauma
Subdural (SDH)Between dura and arachnoidTrauma, bridging vein tear
Epidural (EDH)Between dura and skullTrauma, middle meningeal artery
Intraventricular (IVH)Within ventriclesExtension from ICH, SAH

Intracerebral Hemorrhage by Location:

Location% of ICHEtiology
Basal ganglia/Thalamus50%Hypertension
Lobar35%CAA, tumor, AVM
Cerebellum10%Hypertension
Brainstem5%Hypertension (high mortality)

Epidemiology

  • ICH incidence: 10-30 per 100,000/year
  • SAH incidence: 6-9 per 100,000/year
  • ICH mortality: 30-50% at 30 days
  • SAH mortality: 25-50% overall
  • Age: Increases with age; median age 65-70 for ICH
  • Anticoagulation-related: 12-20% of all ICH (increasing)

Etiology

Intracerebral Hemorrhage:

CauseRisk Factors
Hypertension (60-70%)Uncontrolled HTN, noncompliance
Cerebral amyloid angiopathy (10-30%)Age >5, recurrent lobar
AnticoagulationWarfarin, DOACs, heparin
Vascular malformationsAVM, cavernoma, aneurysm
Hemorrhagic transformation of ischemic strokePost-tPA, large infarct
Tumor-relatedPrimary or metastatic
Cocaine/AmphetaminesDrug-induced HTN
CoagulopathyDIC, liver failure, thrombocytopenia

Subarachnoid Hemorrhage:

CauseFrequency
Aneurysm rupture85%
TraumaVariable
Perimesencephalic (benign)10%
AVM/DAVF5%
Other (coagulopathy, vasculitis, drugs)<5%

Pathophysiology

Intracerebral Hemorrhage Progression

  1. Initial hemorrhage: Vessel rupture (arteriole in HTN, small vessels in CAA)
  2. Hematoma formation: Blood accumulates in parenchyma
  3. Hematoma expansion: Occurs in 30-40% within first hours (poor prognosis)
  4. Mass effect: Compression of adjacent tissue, midline shift
  5. Cerebral edema: Perihematomal edema develops over days
  6. Secondary injury: Inflammation, blood breakdown products, ischemia

Factors Promoting Hematoma Expansion

  • Elevated blood pressure
  • Anticoagulation
  • Coagulopathy
  • "Spot sign" on CTA (active extravasation)
  • Early presentation (<3 hours)

Subarachnoid Hemorrhage Pathophysiology

  1. Aneurysm rupture: Sudden high-pressure bleeding into subarachnoid space
  2. Acute effects: Increased ICP, decreased CBF, loss of consciousness
  3. Early brain injury: Global ischemia, cortical spreading depression
  4. Rebleeding risk: Highest in first 24 hours (4% on day 1)
  5. Vasospasm: Days 3-14 (peaks day 7-10); major cause of delayed morbidity
  6. Hydrocephalus: Acute or chronic; blood blocks CSF absorption

Herniation Syndromes

TypePathologySigns
UncalTemporal lobe through tentoriumIpsilateral dilated pupil, contralateral hemiparesis
CentralDownward bilateral displacementBilateral pupil dilation, posturing
SubfalcineUnder falx cerebriContralateral leg weakness
TonsillarThrough foramen magnumRespiratory arrest

Clinical Presentation

Intracerebral Hemorrhage

Symptoms:

Symptoms by Location:

LocationPresentation
Basal gangliaContralateral hemiparesis, hemisensory loss
ThalamusHemisensory loss, small reactive pupils, downgaze palsy
LobarFocal signs depend on lobe; seizures more common
CerebellumAtaxia, vertigo, nausea, headache, cranial nerve palsies
PontineComa, quadriplegia, pinpoint pupils, high mortality

Subarachnoid Hemorrhage

Classic Presentation:

"Warning Leak" (Sentinel Headache):

Physical Examination

General:

Neurological:

FindingSignificance
Pupil asymmetryHerniation (CN III compression)
HemiparesisContralateral lesion
Gaze deviationToward lesion (hemispheric); away from lesion (brainstem)
MeningismusSAH
PapilledemaElevated ICP (takes hours to develop)
Subhyaloid hemorrhageSAH (Terson syndrome)

Sudden onset headache (often severe)
Common presentation.
Focal neurological deficit (depending on location)
Common presentation.
Altered consciousness
Common presentation.
Nausea, vomiting
Common presentation.
Seizure (5-10%)
Common presentation.
Red Flags

Immediate Life Threats

FindingConcernAction
Unilateral dilated pupilUncal herniationOsmotherapy, hyperventilation, emergent surgery
GCS ≤8Unable to protect airwayIntubate
Cushing's triadElevated ICPOsmotherapy, neurosurgery
Rapidly declining GCSHematoma expansion or herniationRepeat CT, emergent intervention
SeizureOngoing neuronal injuryBenzodiazepines, antiepileptic loading
Anticoagulated + ICHOngoing bleedingImmediate reversal

Poor Prognostic Indicators (ICH)

  • Large hematoma volume (>30 mL supratentorial, >15 mL infratentorial)
  • Intraventricular extension
  • Low GCS at presentation
  • Age >80
  • Anticoagulation
  • Infratentorial location
  • Spot sign on CTA (ongoing bleeding)

Differential Diagnosis

Other Causes of Sudden Severe Headache

DiagnosisFeaturesEvaluation
Ischemic strokeFocal deficit without headache typicallyCT, MRI
MigrainePrior history, aura, photophobiaClinical
Cervical artery dissectionNeck pain, Horner's, focal signsCTA neck
MeningitisFever, meningismus, photophobiaLP
Reversible cerebral vasoconstriction syndromeRecurrent thunderclap headachesCTA/MRA
Pituitary apoplexyVisual loss, ophthalmoplegiaMRI pituitary
Hypertensive encephalopathySeverely elevated BP, no focal signsPRES on MRI

Diagnostic Approach

Imaging

CT Head Non-Contrast (First-Line):

  • Immediately abnormal for acute hemorrhage
  • Identifies location, volume, mass effect, hydrocephalus
  • Sensitivity for SAH: 95-100% in first 6 hours; decreases with time

CT Angiography (CTA):

IndicationPurpose
SAHIdentify aneurysm
ICH (non-hypertensive location)Look for underlying lesion
"Spot sign" assessmentPredicts hematoma expansion
Young patient with lobar ICHAVM, cavernoma, aneurysm

MRI:

  • Better for underlying lesions, cavernomas
  • Gradient echo/SWI for microbleeds (CAA)
  • Not emergent for diagnosis of acute hemorrhage

Lumbar Puncture (SAH):

  • Indicated if CT negative but high clinical suspicion for SAH
  • Wait 6-12 hours after symptom onset for xanthochromia to develop
  • Findings: Elevated RBCs (non-clearing), xanthochromia (yellow supernatant)

Cerebral Angiography (DSA):

  • Gold standard for aneurysm characterization
  • May be needed if CTA inconclusive
  • Performed by neurosurgery/neurointerventional

Laboratory Studies

TestPurpose
CBCPlatelet count, anemia
PT/INR, aPTTAnticoagulation status
FibrinogenDIC, liver disease
BMPBaseline renal function
Type and screenPrepare for surgery/transfusion
GlucoseHypoglycemia as cause of symptoms
Drug screenCocaine, amphetamines

ICH Volume Estimation (ABC/2 Method)

Volume (mL) = (A × B × C) / 2
  • A = largest diameter in cm
  • B = perpendicular to A on same slice
  • C = number of slices with hemorrhage × slice thickness

Treatment

Principles of Management

  1. Airway protection: Intubate if GCS ≤8
  2. Blood pressure control: Reduce hematoma expansion
  3. Reverse anticoagulation: Urgently
  4. Prevent secondary injury: Glucose control, temperature, prevent seizures
  5. Manage elevated ICP: Osmotherapy, surgery if indicated
  6. Neurosurgery consultation: Early and always

Blood Pressure Management

Intracerebral Hemorrhage (AHA/ASA Guidelines):

Presenting SBPTargetRationale
150-220 mmHg<140 mmHgSafe; may reduce hematoma expansion
>20 mmHgAggressive reductionConsider continuous infusion

Agents:

AgentDoseNotes
Nicardipine5-15 mg/hr IVTitratable; first-line
Labetalol10-20 mg IV q10-20minMax 300 mg
Clevidipine1-2 mg/hr IVTitratable
Hydralazine10-20 mg IVLess preferred (unpredictable)

Subarachnoid Hemorrhage:

  • More permissive BP until aneurysm secured
  • Avoid hypotension (reduces perfusion)
  • Target SBP <160-180 mmHg typically

Anticoagulation Reversal

Warfarin:

AgentDoseNotes
4-factor PCC (Kcentra)25-50 units/kgRapid reversal; INR-based dosing
Vitamin K10 mg IVTakes hours to work; give concurrently
FFP10-15 mL/kgIf PCC unavailable; slower

DOACs:

DrugReversal Agent
DabigatranIdarucizumab 5g IV
Factor Xa inhibitors (rivaroxaban, apixaban, edoxaban)Andexanet alfa or 4-factor PCC 50 units/kg

Heparin: Protamine (1 mg per 100 units heparin)

Platelet Dysfunction/Thrombocytopenia:

  • Platelet transfusion if count <100,000 and surgery planned
  • DDAVP 0.3 mcg/kg for uremic platelet dysfunction
  • Controversial for aspirin reversal (no proven benefit)

ICP Management

Tier 1:

  • Head of bed 30°, head midline
  • Analgesia and sedation
  • Avoid hyperthermia, hypoxia, hypotension

Tier 2 - Osmotherapy:

AgentDoseNotes
Mannitol1-1.5 g/kg IVOsmolal gap <20; avoid if hypotensive
Hypertonic saline (23.4%)30 mL IVVia central line preferred
Hypertonic saline (3%)250-500 mLCan repeat

Tier 3:

  • Hyperventilation (temporary, PaCO2 30-35)
  • Barbiturate coma
  • Decompressive surgery

Seizure Management

Prophylaxis (Controversial in ICH):

  • AHA guidelines: May consider for lobar ICH (higher seizure risk)
  • Not routinely recommended for deep ICH without seizures
  • Levetiracetam 20 mg/kg IV if used

Treatment of Active Seizures:

  • Benzodiazepines → Levetiracetam or phenytoin loading

Surgical Management

Intracerebral Hemorrhage Indications:

IndicationConsideration
Cerebellar hemorrhage > cmEmergent surgery
Cerebellar with brainstem compressionEmergent surgery
Lobar clot >0 mL, <1 cm from surfaceConsider evacuation
Deteriorating from mass effectConsider surgery

Subarachnoid Hemorrhage:

  • Aneurysm securing: Surgical clipping or endovascular coiling
  • Timing: Within 24-72 hours preferred
  • EVD placement for hydrocephalus

Subdural Hematoma:

  • Surgical evacuation for: Thickness >10mm, midline shift >5mm, GCS drop ≥2

Epidural Hematoma:

  • Emergent craniotomy for symptomatic EDH or volume >30 mL

SAH-Specific Management

Nimodipine: 60 mg PO q4h × 21 days (reduces vasospasm-related poor outcome)

Vasospasm Monitoring: Transcranial Doppler, clinical exam

Triple-H Therapy (if vasospasm): Hypertension, hypervolemia, hemodilution (after aneurysm secured)


Disposition

ICU Admission

  • All ICH patients require ICU admission
  • Dedicated Neurological ICU if available
  • Frequent neurological checks (q1h)
  • Continuous blood pressure monitoring

Neurosurgery Consultation

  • Immediate for all intracranial hemorrhage
  • Surgical decision-making
  • ICP monitoring placement if indicated
  • EVD for hydrocephalus

Transfer Considerations

  • Transfer to comprehensive stroke center if surgery/intervention needed
  • Time-critical; do not delay
  • Stabilize before transfer (intubation, BP control, reversal started)

Goals of Care

  • Early goals of care discussion
  • Avoid early withdrawal of care (prognostication unreliable in first 24-48h)

Patient Education

For Families

  • "Your loved one has bleeding in the brain, which is very serious."
  • "We are working to stop the bleeding from getting bigger and to protect the brain."
  • "They will need intensive care and possibly surgery."
  • "The next few days are critical for understanding how they will recover."

Long-Term (Survivors)

  • Blood pressure control is critical for prevention
  • Medication compliance
  • Follow-up imaging
  • Rehabilitation services
  • Driving restrictions

Prevention for At-Risk Patients

  • Blood pressure control (most important)
  • Avoid excessive anticoagulation
  • Avoid cocaine and amphetamines
  • Recognize warning signs

Special Populations

Anticoagulated Patients

  • Highest priority: STOP and REVERSE anticoagulation immediately
  • Higher mortality without reversal
  • Do not wait for repeat imaging to start reversal

Elderly

  • Higher prevalence of CAA
  • More likely to be on anticoagulation
  • Higher mortality
  • Frailty impacts prognosis and surgical candidacy

Young Patients with ICH

  • More likely to have underlying vascular lesion (AVM, aneurysm)
  • More aggressive imaging workup
  • Better recovery potential

Pregnancy

  • Eclampsia as cause of ICH
  • SAH risk increases in pregnancy
  • Multidisciplinary management
  • Consider delivery for term or near-term

Warfarin Users

  • 7× increased risk of ICH
  • Rapid reversal essential
  • PCC preferred over FFP

Quality Metrics

Performance Indicators

MetricTargetRationale
CT head within 25 minutes100%Rapid diagnosis
BP <140 mmHg within 1 hour>0%Reduce expansion
Anticoagulation reversal initiated within 30 min100%Stop bleeding
Neurosurgery consultation within 60 min100%Surgical planning
DVT prophylaxis initiated (after 24-48h)100%Prevent VTE
Goals of care documented100%Appropriate care

Documentation Requirements

  • Time of symptom onset
  • Initial and serial GCS
  • Blood pressure and management
  • Anticoagulation status and reversal
  • CT findings including volume
  • Neurosurgery consultation
  • Goals of care discussion

Key Clinical Pearls

Diagnostic Pearls

  • Thunderclap headache = SAH until proven otherwise: LP if CT negative
  • CT negative doesn't rule out SAH >6 hours: Need LP
  • Spot sign on CTA: Active bleeding; predicts expansion
  • Lobar hemorrhage in elderly: Think CAA
  • Young patient + lobar ICH: Always look for underlying lesion
  • Sentinel headache: May precede major SAH by days to weeks

Treatment Pearls

  • Aggressive BP control for ICH: SBP <140 is safe
  • Reverse anticoagulation immediately: PCC not FFP
  • Careful with fluids: Avoid overload
  • Mannitol needs good perfusion: Avoid if hypotensive
  • Nimodipine for SAH: Oral, not IV (causes hypotension)
  • Don't withdraw care early: Wait 48 hours minimum for prognosis

Disposition Pearls

  • All ICH to ICU: No exceptions
  • Cerebellar hemorrhage: Low threshold for surgery (can herniate rapidly)
  • Goals of care early but not too early: Initial 24-48h prognosis unreliable
  • Rehabilitation planning: Start early for survivors

References
  1. Hemphill JC, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. Stroke. 2015;46(7):2032-2060.
  2. Connolly ES, et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage. Stroke. 2012;43(6):1711-1737.
  3. Anderson CS, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355-2365.
  4. Frontera JA, et al. Guidelines for reversal of antithrombotics in intracranial hemorrhage. Neurocrit Care. 2016;24(1):6-46.
  5. Qureshi AI, et al. Intracerebral haemorrhage. Lancet. 2009;373(9675):1632-1644.
  6. Diringer MN, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):211-240.
  7. Steiner T, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9(7):840-855.
  8. UpToDate. Spontaneous intracerebral hemorrhage: Acute treatment and prognosis. 2024.

At a Glance

EvidenceStandard
Last UpdatedRecently

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines